Neurocritical Care News

A consortium led by Weill Cornell Medicine has been awarded a $14.7 million NIH grant for its research center, which focuses on emerging and existing technologies that provide support for older adults with cognitive impairments.

Patients with MS who took diroximel fumarate reported physical benefits, including slowed disease progression and decreased relapses, according to data presented at the Consortium of Multiple Sclerosis Centers annual meeting.

Marinus Pharmaceuticals Inc. announced the Unites States commercial launch of Ztalmy oral suspension for the treatment of seizures associated with CDKL5 deficiency disorder in patients aged 2 years and older.

Quanterix Corp. announced the validation of a laboratory-developed test to quantitatively measure phospho-Tau 181 concentration in plasma to aid in the diagnosis of Alzheimer’s disease.

In patients with primary progressive MS who experience persistent inflammatory activity, disease-modifying therapies were linked to a reduced risk for becoming wheelchair dependent, according to a study in JAMA Neurology.

Cognivue, a neuroscience company, announced it will launch a national study to differentiate the effectiveness of its cognitive assessment systems.

NYU Langone Health has been named the top hospital in the United States for neurology and neurosurgery, according to the latest survey from U.S. News & World Report.

RapidAI has announced FDA clearance for Rapid Hyperdensity, a diagnostic tool that enables physicians to quickly assess the severity of injury in patients with acute conditions, such as traumatic brain injury and brain hemorrhages.

Medesis Pharma has received a grant of 300,000 euros from AFM-Téléthon to fund the first phases of preclinical development of its RNA interference treatment for Huntington’s disease, the company announced.

The Kessler Foundation received multiple grants from the New Jersey Health Foundation for research projects that aim to improve cognition and mobility in patients with neurological disabilities, the foundation announced in a press release.